malaria — grants · GrantIndex

Sort

16,179 grants matching “malaria”

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

$686,250

Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2024 · AI

Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites

$686,225

Akhil B Vaidya · Drexel University · R01 · FY2024 · AI

Discovery of long-acting, chemoprotective antimalarial compounds

$685,970

Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2024 · AI

Great Ape Reservoirs of Human Malaria

$685,899

Beatrice H Hahn · University Of Pennsylvania · R01 · FY2011 · AI

Enhancing Novel Research for Inflammation and Cognitive Health among Adolescents and Young Adults Living with Perinatally Acquired HIV and Adversity (ENRICH+)

$685,637

Reuben N Robbins · Columbia University Health Sciences · R01 · FY2024 · HD

Malaria Vaccines: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT

$685,543

Yimin Wu · Niaid Extramural Activities · Z01 · FY2007 · AI

Evaluating the role of P53 pathways in malaria

$685,219

Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2025 · AI

Impact of early childhood malaria prevention on malaria risk at school entry (ERASE)

$685,104

Miriam K Laufer · University Of Maryland Baltimore · R01 · FY2024 · AI

Development of Pre-Erythrocytic Malaria Vaccines

$685,038

Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Development Of A Vaccine For Leishmania Major Infection

$685,037

Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Production of Adenovector Based Vaccines

$684,896

Duncan L McVey · Genvec, Inc. · R44 · FY2009 · AI

Malaria transmission blocking through mosquito contact with treated surfaces

$684,843

Flaminia Catteruccia · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AI

Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malaria

$684,788

Brian David Foy · Colorado State University · U01 · FY2020 · AI

Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease

$684,323

Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Evaluating the role of P53 pathways in malaria

$684,261

Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2022 · AI

Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum

$683,786

Prakash Srinivasan · Johns Hopkins University · R01 · FY2022 · AI

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

$683,558

Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2022 · AI

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

$683,558

Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2021 · AI

Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections

$683,539

Prasanna Jagannathan · Stanford University · R01 · FY2024 · AI

Conservation and Sustainable Use of Biodiversity in PNG

$683,533

University Of Utah · U01 · FY2003 · TW

Targeting the reproductive interactome of the malaria vector Anopheles gambiae

$683,408

Flaminia Catteruccia · Harvard School Of Public Health · R01 · FY2014 · AI

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

$683,345

Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2020 · AI

Next Generation ELQs for Treatment and Once-Monthly Protection Against Malaria

The role of Î³Î´ T cells in fetal and infant immune defense against malaria

Mapping Drug Resistance Genes in Plasmodium falciparum

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites

Discovery of long-acting, chemoprotective antimalarial compounds

Great Ape Reservoirs of Human Malaria

Enhancing Novel Research for Inflammation and Cognitive Health among Adolescents and Young Adults Living with Perinatally Acquired HIV and Adversity (ENRICH+)

Malaria Vaccines: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT

Evaluating the role of P53 pathways in malaria

Impact of early childhood malaria prevention on malaria risk at school entry (ERASE)

Development of Pre-Erythrocytic Malaria Vaccines

Development Of A Vaccine For Leishmania Major Infection

Production of Adenovector Based Vaccines

Malaria transmission blocking through mosquito contact with treated surfaces

Repeat Ivermectin Mass Drug Administrations for MALaria control II (RIMDAMAL II): a double-blind cluster randomized trial for integrated control of malaria

Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease

Evaluating the role of P53 pathways in malaria

Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections

Conservation and Sustainable Use of Biodiversity in PNG

Targeting the reproductive interactome of the malaria vector Anopheles gambiae

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline